Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2018 Sep 17;84(19):e01337-18. doi: 10.1128/AEM.01337-18

Microbial Cell Factories à la Carte: Elimination of Global Regulators Cra and ArcA Generates Metabolic Backgrounds Suitable for the Synthesis of Bioproducts in Escherichia coli

Diego E Egoburo a, Rocío Diaz Peña a, Daniela S Alvarez a, Manuel S Godoy a,*, Mariela P Mezzina a, M Julia Pettinari a,
Editor: Haruyuki Atomib
PMCID: PMC6146986  PMID: 30030227

Although the effects of many global regulators, especially ArcA and Cra, have been studied in Escherichia coli, the metabolic changes caused by the absence of global regulators have been observed to differ between strains. This scenario complicates the identification of the individual effects of the regulators, which is essential for the design of metabolic engineering strategies. The genome of Escherichia coli BW25113 has been completely sequenced and does not contain additional mutations that could mask or interfere with the effects of the global regulator mutations. The uniform genetic background of the Keio collection mutants enabled the characterization of the physiological consequences of altered carbon and redox fluxes caused by each global regulator deletion, eliminating possible strain-dependent results. As a proof of concept, Δcra and ΔarcA mutants were subjected to further manipulations to obtain large amounts of succinate and 1,3-PDO, demonstrating that the metabolic backgrounds of the mutants were suitable for the synthesis of bioproducts.

KEYWORDS: global regulators; ArcA; Cra; PhaP; 1,3-propanediol; Escherichia coli

ABSTRACT

Manipulation of global regulators is one of the strategies used for the construction of bacterial strains suitable for the synthesis of bioproducts. However, the pleiotropic effects of these regulators can vary under different conditions and are often strain dependent. This study analyzed the effects of ArcA, CreC, Cra, and Rob using single deletion mutants of the well-characterized and completely sequenced Escherichia coli strain BW25113. Comparison of the effects of each regulator on the synthesis of major extracellular metabolites, tolerance to several compounds, and synthesis of native and nonnative bioproducts under different growth conditions allowed the discrimination of the particular phenotypes that can be attributed to the individual mutants and singled out Cra and ArcA as the regulators with the most important effects on bacterial metabolism. These data were used to identify the most suitable backgrounds for the synthesis of the reduced bioproducts succinate and 1,3-propanediol (1,3-PDO). The Δcra mutant was further modified to enhance succinate synthesis by the addition of enzymes that increase NADH and CO2 availability, achieving an 80% increase compared to the parental strain. Production of 1,3-PDO in the ΔarcA mutant was optimized by overexpression of PhaP, which increased more than twice the amount of the diol compared to the wild type in a semidefined medium using glycerol, resulting in 24 g · liter−1 of 1,3-PDO after 48 h, with a volumetric productivity of 0.5 g · liter−1 h−1.

IMPORTANCE Although the effects of many global regulators, especially ArcA and Cra, have been studied in Escherichia coli, the metabolic changes caused by the absence of global regulators have been observed to differ between strains. This scenario complicates the identification of the individual effects of the regulators, which is essential for the design of metabolic engineering strategies. The genome of Escherichia coli BW25113 has been completely sequenced and does not contain additional mutations that could mask or interfere with the effects of the global regulator mutations. The uniform genetic background of the Keio collection mutants enabled the characterization of the physiological consequences of altered carbon and redox fluxes caused by each global regulator deletion, eliminating possible strain-dependent results. As a proof of concept, Δcra and ΔarcA mutants were subjected to further manipulations to obtain large amounts of succinate and 1,3-PDO, demonstrating that the metabolic backgrounds of the mutants were suitable for the synthesis of bioproducts.

INTRODUCTION

Most bacteria are able to live in and adapt to many different conditions, displaying various degrees of metabolic flexibility. For example, facultative aerobes such as Escherichia coli can modify their metabolic pathways to optimize the use of different electron acceptors or carbon sources (1, 2). Gene expression is regulated by a network of regulators that orchestrates the transcription of genes in response to environmental stimuli, allowing cells to survive and grow in a variety of conditions. Recent studies that analyzed promoter activity across 26 different environmental conditions showed that, despite the existence of a dense and complex regulation network, a few global regulators are responsible for 70% of the changes, particularly those that affect central carbon metabolism (3). The extensive regulation network controlled by these regulators allows them to maintain cellular homeostasis by simultaneously controlling carbon flux and reducing power (4). Therefore, global regulators have been targeted to manipulate carbon metabolism and redox balance in order to generate genetic backgrounds suitable for the enhanced production of biotechnologically relevant compounds (5).

Metabolic adaptation to carbon source availability is crucial for bacteria. In E. coli, two main global mechanisms regulate carbon catabolism: Crp (for cyclic AMP receptor protein) (6) and Cra (for catabolite repressor/activator) (7). Cra controls carbon flux by direct repression of glycolytic enzymes and activation of tricarboxylic acid (TCA) cycle and gluconeogenic enzymes (8). In addition, E. coli has recently been proposed to be capable of sensing the glycolytic flux and accomplish flux-dependent regulation through the interaction of Cra with its effector 1,6-fructose bisphosphate (3, 9). The number of genes known to be part of the cra regulon has increased to include genes involved in stress response and nitrogen metabolism, previously unidentified transcription factors related to carbon metabolism, and even the global regulator Crp (10, 11).

The two-component system ArcAB is one of the major regulators of respiration pathways in E. coli in response to redox conditions (12). ArcB, a transmembrane sensor kinase, senses oxygen availability, and ArcA controls gene expression according to ArcB signaling (13). The main targets of this regulator are genes involved in central carbon metabolism. It represses TCA cycle enzymes in both microaerobic (14) and aerobic (15) conditions and activates fermentative enzymes (16). Previous studies in our laboratory have demonstrated that the inactivation of this global regulator led to an increase in the synthesis of reduced chemicals such as poly(3-hydroxybutyrate) (PHB) and ethanol (EtOH) (4, 17).

Another important two-component system, CreBC (for carbon source responsive), is a global regulator of intermediate metabolism which is active during microaerobic conditions when glycolytic carbon sources are used in minimal medium (18). Numerous gene targets have been detected for this regulator by microarray analysis (19). Deletion of creC has been observed to affect redox potential and central carbon metabolism in E. coli, creating a metabolic background suitable for succinate synthesis (20).

Metabolic flux experiments revealed a shared control of ArcAB and CreBC in the regulation of redox state and carbon substrate utilization under restricted oxygen conditions. Both systems modulate the activity of the pyruvate branch, the pentose phosphate pathway, and the TCA cycle (21). Previous studies in our group using ΔarcA mutants with a creC constitutive allele resulted in a remarkable increase in the synthesis of reduced chemicals in E. coli K1060 (4). The cre operon and arcA are adjacent in chromosomal location in a genomic region that also contains the gene coding for a third transcription factor, Rob, located next to the cre operon. Rob activates several genes belonging to the overlapping MarA/SoxS/Rob regulon, implicated in antibiotic and heavy metal resistance, organic solvent tolerance, and carbon metabolism, and has been shown to affect TCA cycle and glycolysis enzymes (22). Although the effects of Rob have not been thoroughly investigated, it reportedly activates regulatory proteins, suggesting that its regulatory effects could be more extensive (23). The known characteristics of this little-studied regulator make Rob a potentially interesting target for metabolic manipulations.

Other global regulators have also been observed to affect the tolerance of different strains of E. coli to diverse stress factors. Cra reportedly affects stress-related genes (10). The absence of ArcA caused an increase in sensitivity to organic solvents, and in contrast, deletion of crp in the same strain caused higher tolerance to n-hexane (24). ArcA has also been demonstrated to control the gadE-mdtEF operon (25) involved in acid and multidrug resistance (26). These results suggest that manipulation of global regulators can affect the tolerance of bacteria to different chemicals, including compounds of biotechnological interest.

Although several studies have analyzed the effect of global regulator manipulations on metabolism and the synthesis of several bioproducts, many of them have utilized E. coli strains with unsequenced genomes (4, 20) or strains carrying mutations in genes involved in central metabolism (27). These factors hinder the correct interpretation of the effects of global regulator manipulations per se, since the pleiotropic and complex effects of these regulators over metabolism and physiology can vary in different genetic backgrounds. Based on studies performed in E. coli MC4100, it was believed that ArcA was exclusively involved in the maintenance of the redox state in microaerobiosis, since no significant changes in flux analysis were seen under fully aerobic and anaerobic conditions (28). However, metabolic flux analysis of chemostat cultures of strain BW25113, using glucose as a carbon source, revealed important changes in the TCA cycle, in the pentose phosphate pathway, and also in the pyruvate dehydrogenase complex in arcA and/or arcB mutants grown in both microaerobic (29) and aerobic (15) conditions. Similar differences have been observed when comparing the effects of other global regulators, such as cre, in E. coli strains in several growth conditions (20). A comparative study of the transcriptional and metabolic effects of the Δcra mutation in two E. coli strains showed that the Δcra deletion led to very different phenotypes in strains JM109 and BL21 due to differences in their regulatory targets, such as the bet operon genes, that were affected by the Δcra deletion in JM109 but not in BL21 (30). This strain dependence complicates the identification of the changes that can be attributed to each global regulator, so comparative studies in a uniform genetic background are needed for a better understanding of the effects of the manipulation of the global regulators on cell physiology and particularly on central metabolism.

In the present study, we investigated the effect caused by the absence of global regulators ArcA, CreC, Rob, and Cra using single-knockout mutants of E. coli BW25113 from the Keio collection. This strain has a well-defined pedigree not subjected to mutagens, and its genome has been completely sequenced (31, 32). The effects of the absence of each regulator on physiology and growth were analyzed at different oxygen concentrations by metabolic profiling and stress tolerance assays. The suitability of the different metabolic backgrounds for the synthesis of several bioproducts was tested, and the strains with the best performance were subjected to further manipulation to enhance the production of succinate and 1,3-propanediol (1,3-PDO). The results obtained contribute to a better understanding of the effects of the most relevant global regulators involved in central carbon metabolism and redox regulation in E. coli and reveal suitable genetic backgrounds for the production of added-value compounds.

RESULTS AND DISCUSSION

Effects of the absence of global regulators on metabolism and physiology of E. coli BW25113. (i) Metabolic profile of global regulator mutants.

When the synthesis of organic acids was studied in cultures of each mutant grown in M9 medium supplemented with 5 g liter−1 glucose under low-aeration conditions, all global regulators were observed to affect metabolite distribution. The Δrob strain showed an increase in lactic, formic, and acetic acids, while increases in the synthesis of acetate and lactate were also detected in the ΔcreC and ΔarcA mutants, respectively, compared to the control strain (Fig. 1A). Elimination of Cra seemed to affect the formation of all acids. Significant increases were seen for pyruvate (1.6-fold), succinate (2.5-fold), and lactate (1.5-fold) compared to the wild type (Fig. 1A). Levels of glucose consumption were similar for all strains (see Fig. S1 in the supplemental material), but biomass formation was lower for the ΔarcA and Δcra mutants compared to the wild-type strain (Fig. 1A). These data suggest that carbon distribution was directed toward the synthesis of organic acids in Δcra mutants and mostly to lactate in the ΔarcA background. This could be explained by an increase in carbon flux through glycolysis and repression of the TCA cycle that has been previously reported in Δcra mutants (7) and by the funneling of carbon toward the synthesis of reduced compounds in the case of the ΔarcA mutant (4).

FIG 1.

FIG 1

Metabolic profiles of global regulator mutants. Cultures were grown in M9 supplemented with glucose at 5 g liter−1 in shaken flasks under low-aeration conditions. The strains used were E. coli BW25113 as the control (wild type) and its mutant derivatives (Δrob, Δcra, ΔarcA, and ΔcreC). (A) Results represent the mean values ± the standard deviations of each metabolite and biomass measured in the supernatants after 24 h from at least three independent replicates. An asterisk (*) indicates significant differences when comparing mutant strains to the wild-type strain (t test, P < 0.05, n = 6). (B) Unsupervised PCA was applied to the organic acid profile of all strains using metabolite concentrations relativized to the final biomass (g metabolite · g CDW−1). The original variables are displayed in the graphic, and values of triplicates from at least two independent experiments were used (n = 6).

When EtOH was measured under low-aeration conditions, no changes in alcohol production were detected in the mutants except for the ΔcreC strain, in which a slight but significant increase was observed compared to the control strain (0.12 ± 0.01 g liter−1 and 0.09 ± 0.02 g liter−1, respectively) (Fig. 1A). In addition, the metabolic profiles of nonaerated cultures of the Δcra and Δrob mutants were also determined, since the information available on the effects of these regulators under this condition is scarce for Cra and is not available for Rob. Although the Δrob strain showed important increases in the synthesis of lactate, formate, and acetate, accompanied by a modest decrease in biomass when grown under low aeration (Fig. 1A), under nonaerated conditions the Δrob mutant did not show significant differences compared to the control strain (Table 1). In contrast, the increase in acid formation observed for the Δcra mutant compared to the control was even more marked in nonaerated cultures than under low aeration. Fermentation acids increased around 2-fold, while a 30% reduction in biomass formation was observed for the nonaerated cultures of the Δcra strain compared to the wild type (Table 1). This is similar to the results observed under low-aeration conditions (Fig. 1A) and suggests that carbon is being used for acid synthesis rather than for biomass production in this mutant under both conditions tested.

TABLE 1.

Organic acid production by wild-type, Δcra, and Δrob strains under nonaerated conditionsa

Strain Metabolite synthesis (g · liter−1)
Glucose consumption (g · liter−1)
Pyruvate Succinate Lactate Formate Acetate Biomass
Wild type 0.03 ± 0.01 0.44 ± 0.08 0.97 ± 0.14 1.2 ± 0.2 0.8 ± 0.1 0.26 ± 0.02 4.4 ± 0.6
Δcra 0.06 ± 0.01* 0.94 ± 0.14* 1.70 ± 0.50* 1.7 ± 0.3* 1.3 ± 0.4* 0.19 ± 0.01* 5.3 ± 0.3
Δrob 0.03 ± 0.01 0.47 ± 0.70 1.00 ± 0.08 1.1 ± 0.4 0.9 ± 0.2 0.22 ± 0.03 4.7 ± 0.3
a

Cultures were grown in M9 medium supplemented with glucose at a 5 g · liter final concentration under nonaerated conditions. The strains used were E. coli BW25113 (wild type) and its Δcra and Δrob derivatives. Results represent means ± the standard deviations from independent replicates (n = 6). *, significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05).

Comparison with the results reported in previous studies showed that, whereas the results obtained using the same strains were consistent, such as the higher acid production in the Δcra mutants (33), the results obtained with other strains varied. For example, the increase in the formation of organic acids in the ΔarcA and ΔcreC mutants reported here was also observed in K1060 derivatives containing the same mutations (20, 34), but contrasting results were found when EtOH synthesis data were compared. While the ΔcreC derivative of BW25113 displayed higher EtOH amounts than the wild type, the EtOH levels produced by the ΔcreC derivative of strain K1060 and its parent strain did not differ (20). The opposite was observed when the ΔarcA mutants were analyzed, since while the K1060 derivative had increased EtOH production (35), no differences were observed for the Keio collection strain in the present study.

Unsupervised principal component analysis (PCA) was applied to the metabolic profiles obtained in low-aeration glucose cultures. Two principal components interpreted 60% of the variance. The analysis showed that all regulators affected carbon distribution in E. coli BW25113 under the conditions tested, since a clear separation was found between all mutations and the wild-type strain. In addition, the Δcra mutant displayed an evident separation not only from the wild type but also from the ΔarcA, ΔcreC, and Δrob strains (Fig. 1B).

(ii) Tolerance assays.

Previous studies performed with strains containing variants of different global regulators showed that these changes can affect the tolerance to several chemicals and other stressors (10, 24). Industrial bioprocesses are associated with high-density cultures in which cells are exposed to several stresses, including osmotic and redox stress and high concentrations of the bioproducts, some of which can be cytotoxic (36). The possibility that the regulators analyzed in in the present study could affect tolerance to different stressors was studied in order to assess the potential fitness of the mutants in biotechnological processes. The tolerance of the mutants to osmotic stress (NaCl) and to the bioproducts EtOH, butanol (ButOH), and 1,3-PDO was determined. Sensitivity to redox stress caused by toluidine blue was also determined, since the Dye phenotype, an increase in sensitivity to this redox dye attributed to reactive oxygen species (ROS) accumulation due to a higher rate of oxygen consumption (37), was one of the first effects attributed to the loss of ArcA (37).

Only small differences in tolerance were seen for the different mutants under all conditions tested, except for the Δcra strain, which showed an increased sensitivity to EtOH and ButOH and to toluidine blue. The tolerance to osmotic stress of this strain was comparable to the wild type under full-aeration conditions and slightly but significantly lower under full-aeration conditions (Table 2). In contrast, the ΔarcA deletion had no relevant negative effects on tolerance, except for the well-known increase in sensitivity to toluidine blue (37) and a little decrease in growth in the presence of 3.5% (wt/vol) NaCl in restricted aeration (Table 2). Moreover, a slightly increased tolerance to 7% (wt/vol) 1,3-PDO was detected for this strain (Table 2). In the case of the ΔcreC strain, the only discernible effect was a slight increase in the sensitivity to 1,3-PDO under low aeration (Table 2). Finally, Δrob mutants did not exhibit appreciable differences compared to the wild type.

TABLE 2.

Tolerance assays for global regulator mutant strains under different oxygen availability conditionsa

Strain Tolerance (%)
FA
LA
Plates (TB)
EtOH 1,3-PDO ButOH NaCl EtOH 1,3-PDO ButOH NaCl
Wild type 28.0 ± 0.3 48 ± 15 2 ± 1 71 ± 10 7 ± 2 28 ± 9 35 ± 4 43 ± 8 87 ± 15
Δrob 26 ± 5 37 ± 1 13 ± 6 70 ± 7 7 ± 2 32 ± 7 41 ± 2 37 ± 5 86 ± 4
Δcra NG 36 ± 1 NG 50 ± 8 NG NG NG 50 ± 5 45 ± 16*
ΔcreC 25 ± 13 36 ± 4 2 ± 2 75 ± 14 8 ± 2 6 ± 3* 37 ± 2 54 ± 9 78 ± 15
ΔarcA 37 ± 11 39 ± 4 3 ± 1 42 ± 10* 9 ± 2 42 ± 5* 39 ± 5 44 ± 9 26 ± 9*
a

All values are expressed as percentages of bacterial growth relative to growth in medium with no stress agent. For solvent and salt stress, shaken-flask cultures were grown in M9 supplemented with glucose at 5 g · liter−1 under both low-aeration and fully aerated conditions. The strains assayed were E. coli BW25113 (wild type) and its Δcra and ΔarcA derivatives. Cells were exposed to different stress agents for 24 h at 37°C. Redox stress, induced by toluidine blue, is expressed as a percentage of the colony diameter formed in M9 agar medium with glucose at 5 g · liter−1 plus toluidine blue at 0.02% relative to growth in the same medium with no stain. Results represent means ± the standard deviations from 3 independent measurements (10 in the case of TB). *, significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05). FA, full aeration; LA, low aeration. The concentrations of stress agents used, expressed in % (wt/vol), were as follows: EtOH (ethanol), 4.8% in FA and 4.4% in LA; 1,3-PDO (1,3-propanediol), 7% in FA and LA; ButOH (butanol), 0.8% in FA and 0.6% in LA; NaCl, 3.5% in FA and LA; and TB (toluidine blue), 0.02%. NG, no growth.

The PCA, including all tolerance results, showed that the Δcra mutant, which was extremely sensitive to many of the compounds tested, especially under low-aeration conditions, was clearly separated from the rest by the maximum distance, followed by the ΔarcA strain, while the distribution of the Δrob and ΔcreC strains partially overlapped with wild-type E. coli. PC1 and PC2 explained 61% of the total variance in this analysis (Fig. 2). The increased sensitivity of the Δcra knockout strain could be explained by changes in the stress response, since several stress response regulators have been identified as putative Cra targets (10). In addition, a decreased expression of the bet operon, responsible for osmotic homeostasis, has been reported in JM109 Δcra mutants (30). The increased sensitivity to toluidine blue observed for Δcra mutants in this study could be an indicator of redox stress and increased ROS production, similar to the Dye phenotype observed in ΔarcA strains (37). The unexpected lack of sensitivity to the different compounds observed for the Δrob mutant could be due to the characteristics of the MarA/SoxS/Rob regulon. These regulators share the control of many stress-related genes (22), so it is possible that the absence of Rob can be compensated by the activity of MarA or SoxS.

FIG 2.

FIG 2

Tolerance assays of global regulator mutants. Unsupervised PCA was applied to the response of all strains to different stress agents. The original variables are displayed in the graphic, and values of triplicates from at least two independent experiments were used (n = 6). FA, full aeration; LA, low aeration. The concentrations of stress agents are expressed as the percentage (wt/vol).

Identification of suitable genetic backgrounds for bioproduct synthesis.

Following the analysis of the metabolite profiles and tolerance of the mutants, the effect of each deletion was studied in several strains containing heterologous genes that increase the synthesis of EtOH or allow the production of the nonnative products PHB and 1,3-PDO. The production of these compounds was assayed in cultures of each mutant grown for 24 h in different media and aeration conditions at 37°C.

(i) Ethanol.

EtOH production was measured in all mutants containing a plasmid that carries adhE from Leuconostoc mesenteroides in cultures grown under low-aeration conditions in lysogeny broth (LB) supplemented with glucose or glycerol at 10 g · liter−1 final concentration. When glucose was used, ΔarcA and ΔcreC mutants produced 2-fold more EtOH and a higher yield compared to the wild type (Table 3). No differences were observed for the Δrob and Δcra mutants compared to the wild-type strain. The improved EtOH synthesis in ΔarcA glucose cultures in this work was similar to the increase observed in other ΔarcA strains (34) and has been related to a higher availability of reducing power. The increase in EtOH synthesis observed for the ΔcreC mutant was not reported in other strains but is consistent with the effect of CreC observed in the nonrecombinant strains reported here (Fig. 1A).

TABLE 3.

Ethanol production in strains expressing adhEa

Strain Concn (g · liter−1)
Specific production (mol EtOH · mol CDW−1)
Yield (mol EtOH · mol S−1)
Substrate consumption (g · liter−1)
Glucose Glycerol Glucose Glycerol Glucose Glycerol Glucose Glycerol
Wild type 0.30 ± 0.04 0.73 ± 0.06 0.29 ± 0.03 0.56 ± 0.03 0.3 ± 0.1 0.45 ± 0.14 5 ± 1 3.5 ± 1.0
Δrob 0.32 ± 0.07 0.85 ± 0.12 0.26 ± 0.06 0.65 ± 0.06 0.2 ± 0.1 0.42 ± 0.03 6 ± 1 4.1 ± 0.8
Δcra 0.39 ± 0.02 0.47 ± 0.02* 0.34 ± 0.03 0.42 ± 0.04* 0.4 ± 0.2 0.27 ± 0.02* 5 ± 1 3.5 ± 0.4
ΔarcA 0.67 ± 0.12* 0.38 ± 0.01* 0.53 ± 0.11* 0.28 ± 0.05* 0.95 ± 0.20* 0.30 ± 0.03* 4 ± 1 2.6 ± 0.3
ΔcreC 0.58 ± 0.09* 0.72 ± 0.07 0.57 ± 0.06* 0.55 ± 0.05 0.5 ± 0.1* 0.39 ± 0.08 5 ± 1 3.8 ± 1.0
a

Cultures were grown in shaken flasks using LB medium supplemented with glycerol or glucose (both at a 10 g · liter−1 final concentration) under low-aeration conditions for 24 h. Results represent means ± the standard deviations from at least three independent replicates. All strains harbored the pETLm plasmid (carrying adhE from L. mesenteroides). Expression of adhE was induced by the addition of IPTG at 0.5 mM when cultures reached the early exponential phase (OD600 = 0.8). *, significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05). CDW, cell dry weight; S, substrate.

In cultures supplemented with glycerol, the wild-type, Δrob, and ΔcreC strains had higher EtOH synthesis than the same strains grown using glucose. The larger amounts of EtOH produced with glycerol compared to glucose cultures have been often observed and are attributed to the fact that glycerol is a more reduced carbon source than glucose (38). Unexpectedly, the ΔarcA glycerol cultures produced less EtOH than the corresponding glucose cultures, and both ΔarcA and Δcra strains produced even less EtOH than the wild type when we compared the strains grown on glycerol (Table 3). These results are in contrast to those obtained with a ΔarcA derivative of K1060 (4) and can be related to the low glycerol consumption displayed by the ΔarcA mutant used in the present study (Table 3).

(ii) Poly(3-hydroxybutyrate).

The effect of the different mutations on the synthesis of the biodegradable thermoplastic PHB was also tested. Since E. coli does not produce this polymer naturally, a plasmid containing the PHB synthesis genes from Ralstonia eutropha (also named Cupriavidus necator) was introduced in the different global regulator mutants and in the control strain. The synthesis of this reserve polymer produced by many bacterial species involves the use of carbon and reducing power (17), so mutations that affect carbon fluxes and the redox state of the cells were expected to also affect PHB synthesis. However, cultures of all global regulator mutant derivatives of BW25113 accumulated amounts of PHB similar to the wild type when grown in LB supplemented with glucose under low aeration. Previous work performed in K1060 showed an increase in the polymer content of the ΔarcA mutants (17), but no differences in PHB cell content were observed when the Keio collection ΔarcA mutant was grown under similar conditions (see Fig. S2 in the supplemental material). The discrepancies in the results obtained with the E. coli BW25113 and K1060 ΔarcA derivatives can be attributed to strain differences and point once again to the strain dependence of the global regulator knockout mutant phenotypes.

(iii) 1,3-PDO.

1,3-Propanediol (1,3-PDO) is a high-value bulk chemical with many industrial applications, especially the production of polytrimethylene terephthalate (39). 1,3-PDO can be obtained by microbial fermentation of glycerol, the main by-product of biodiesel production, and thus is an inexpensive and readily available substrate (40). Genes for 1,3-PDO synthesis from Klebsiella pneumoniae GLC29 (41) were used to promote the synthesis of this diol from glycerol; this was studied in cultures of all global regulator mutant strains grown in M9 or LB in full and low aeration. When cultures were grown in M9, no significant differences in 1,3-PDO concentration were observed under any aeration condition. However, a slightly augmented final concentration of 1,3-PDO was detected in the ΔarcA mutant in low aeration despite a 44% reduction in glycerol consumption (Table 4). A similar increase in 1,3-PDO titer was observed for the Δcra mutant, but a higher production per gram of biomass was obtained in this strain due to a decrease in growth, probably due to its reduced capability to use gluconeogenic carbon sources (8). Lastly, the ΔcreC mutant showed a marked decrease in glycerol consumption compared to the parental strain in restricted and fully aerated M9 cultures (about 50 and 40%, respectively) (Table 4). This is in line with previous observations that described an impaired growth of ΔcreC derivatives of DH5α in minimal medium supplemented with glycerol as the sole carbon source (42).

TABLE 4.

Production of 1,3-PDO in strains expressing the dha operona

Strain 1,3-PDO concn (g · liter−1)
Specific production (mol 1,3-PDO · mol CDW−1)
Yield (mol 1,3-PDO · mol Gly−1)
Substrate consumption (g · liter−1)
LA FA LA FA LA FA LA FA
Wild type 0.72 ± 0.08 1.5 ± 0.5 1.50 ± 0.13 0.40 ± 0.07 0.63 ± 0.17 0.17 ± 0.09 1.9 ± 0.3 19 ± 1
Δrob 0.73 ± 0.10 1.00 ± 0.03 1.30 ± 0.12 0.47 ± 0.08 0.53 ± 0.12 0.10 ± 0.01 1.9 ± 0.4 14 ± 3
Δcra 0.88 ± 0.11 1.5 ± 0.3 2.40 ± 0.42* 0.85 ± 0.21* 0.71 ± 0.17 0.23 ± 0.02 1.6 ± 0.3 8 ± 1*
ΔarcA 0.90 ± 0.02 1.6 ± 0.5 1.50 ± 0.12 0.56 ± 0.08 0.81 ± 0.10 0.14 ± 0.07 1.0 ± 0.2* 15 ± 3
ΔcreC 0.66 ± 0.07 1.2 ± 0.3 1.40 ± 0.06 0.35 ± 0.05 0.85 ± 0.03 0.11 ± 0.02 0.9 ± 0.1* 12 ± 1*
a

Cultures were grown in shaken flasks and M9 medium supplemented with glycerol at 10 and 30 g · liter−1 for low-aeration and fully aerated conditions, respectively, for 24 h. Results represent means ± the standard deviations of three independent replicates. All strains harbored plasmid pBBR1MCS-2::dha (carrying the dha operon from K. pneumoniae). *, significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05). Gly, glycerol; LA, low aeration; FA, full aeration; CDW, cell dry weight.

When synthesis of 1,3-PDO was monitored in LB cultures, no differences between strains were observed in low-aeration conditions (data not shown). In contrast, when fully aerated experiments were conducted, a marked increase was found in ΔarcA mutants, which produced >2-fold more 1,3-PDO than all other strains, reaching 10.0 ± 0.2 g liter−1 in 24-h batch cultures (Fig. 3). Glycerol consumption was highly increased in this mutant compared to the wild type, but the substrate was apparently used mostly for the synthesis of the diol, since both 1,3-PDO yields and specific production were increased in the ΔarcA mutants (Table 5). No significant differences in diol concentration were observed between the rest of the mutants and the wild type, including the Δcra strain, which had evidenced higher 1,3-PDO-specific production in minimal medium (Table 4).

FIG 3.

FIG 3

Production of 1,3-propanediol in recombinant E. coli strains. Cultures were grown in shaken flasks in LB supplemented with glycerol at 30 g liter−1 under fully aerated conditions for 24 h. Results represent the mean value ± the standard deviations of three independent replicates. The strains used were E. coli BW25113 as the control (wild type) and its mutant derivatives (Δrob, Δcra, ΔarcA, and ΔcreC). All bacteria harbored plasmid pBBR1MCS-2::dha (carrying the genes for 1,3-PDO synthesis). Yield corresponds to 1,3-PDO on glycerol. An asterisk (*) indicates significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05).

TABLE 5.

Effects of PhaP on the production of 1,3-PDOa

Strain Yield (mol 1,3-PDO · mol Gly−1) Glycerol consumption (g · liter−1) Specific production (mol 1,3-PDO · mol CDW−1)
Wild type 0.39 ± 0.01 16.0 ± 0.4 0.62 ± 0.03
Δcra 0.32 ± 0.02* 12.0 ± 0.6 0.45 ± 0.04*
ΔarcA 0.46 ± 0.02* 32 ± 4* 1.40 ± 0.15*
Wild type+PhaP 0.44 ± 0.01 20.0 ± 0.2 0.92 ± 0.03
ΔarcA+PhaP 0.73 ± 0.01* 28 ± 2* 1.80 ± 0.12*
a

Cultures were grown in LB medium supplemented with glycerol at 30 g · liter−1 in shaken flasks under fully aerated conditions for 24 h. Results represent means ± the standard deviations of triplicates from at least two independent cultures. The strains used were E. coli BW25113 as a control and its Δcra and ΔarcA derivatives. All strains harbored plasmids pBBR1MCS-2::dha (carrying the genes for 1,3-PDO synthesis) and pPhaP328 (carrying phaP from Azotobacter sp. FA8). Expression of phaP was induced in the wild type+PhaP and ΔarcA+PhaP strains by the addition of m-toluic acid at 0.5 mM when the cultures reached the early exponential phase (OD600 = 0.8). *, significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05). Gly, glycerol; CDW, cell dry weight.

Considering that 1,3-PDO synthesis requires reducing power, it is not surprising that the ΔarcA mutants produced larger amounts of this compound. These results are in accordance with the increased synthesis of other reduced metabolites observed in K1060 ΔarcA mutants (43). Unexpectedly, the greatest changes took place in fully aerated conditions and not under low-oxygen conditions, as would be expected considering the results obtained with K1060. Previous metabolic characterizations of the Keio collection ΔarcA mutant revealed important changes in the flux through the TCA cycle under aerobic conditions (15), leading to a greater availability of reducing power that could be funneled in turn to 1,3-PDO synthesis.

Multivariate analysis.

Taking into account all variables observed, the global regulator mutants displayed different phenotypes in a variety of conditions, probably due to the multiplicity of regulatory targets. The results obtained from the metabolic profiles, the tolerance assays, the production of nonnative metabolites (see Table S1 in the supplemental material) and the growth of all strains on minimal medium (see Fig. S3 in the supplemental material) were used to perform a descriptive multivariate analysis to search for patterns that could be associated with each mutant.

In the PCA, PC1 and PC2 explained more than 44% of the total variance and revealed well-defined groups. While during the analysis of each particular set of conditions the strains showing the greatest deviations from the control varied, when all parameters were simultaneously considered in an integral analysis the greatest distances were clearly observed between the wild type and the strains with the Δcra and ΔarcA deletions (Fig. 4A). On the other hand, the Δrob mutants only exhibited differences in organic acid formation compared to the control strain, and this was reflected in an overlap between the two strains on the PCA. Lastly, the ΔcreC strain also overlapped with the Δrob strain and the wild type (Fig. 4A), in spite of some significant differences found when comparing some of the individual characteristics of these strains, such as the production of some acids and ethanol. A hierarchical clustering analysis (HCA) of all data was able to distinguish separate groups corresponding to the wild type and each of the mutants (Fig. 4B). The distances between the clusters were congruent with the separations observed in the PCA, since the Δcra mutant displayed the maximum distance from the wild type, followed by the ΔarcA mutant. The wild type, Δrob, and ΔcreC strains were clustered in distinct but closely related groups.

FIG 4.

FIG 4

Multivariate analysis of the effect caused by the absence of different global regulators on E. coli BW25113. Descriptive multivariate analysis was performed by PCA (A) and HCA (B). Both statistics were based on 21 variables, including production of native and nonnative metabolites, growth on M9, and tolerance assays (see Table S1 and Fig. S3 in the supplemental material for detailed information). Values of triplicates from two independent experiments were used (n = 6).

The different multivariate analyses, including PCA and HCA, showed specific patterns for each mutation despite the extensive regulation exerted by the global transcription factors and their coregulation of some gene targets (44, 45). Discriminant analysis also yielded similar results (see Fig. S4 in the supplemental material). The two global regulators that showed the most distinctive effects were Cra and ArcA, an observation in agreement with studies that indicated that Cra is the main regulator of central carbon metabolism (46) and that ArcA controls either directly or indirectly a very important part of all genes in E. coli (47). Taking into account the physiological background created by each of the global regulator mutations, the Δcra and ΔarcA mutants can be considered suitable for the synthesis of some bioproducts.

Metabolic manipulation of the Δcra mutant for enhanced succinate production.

The metabolic profiles of the Δcra knockout strain showed increased succinate synthesis under both low-aeration and nonaerated conditions, but the greatest differences were observed in the nonaerated cultures. A strategy that was observed to increase succinate in other strains (20) was used to improve the production of this valuable compound in the Δcra background. Briefly, fdh1, encoding formate dehydrogenase 1 from the yeast Candida boidinii, was overexpressed to convert the excess formic acid produced by the Δcra mutants into CO2 and reducing power, and pck, encoding pyruvate carboxy kinase (Pck), was used to enhance the synthesis of oxalacetate through the carboxylation of phosphoenolpyruvate in an anaplerotic reaction. The phosphoenolpyruvate can subsequently react with the CO2 and reducing equivalents to generate succinic acid. Plasmids pSBF2 (carrying fdh1) and pEcpck (carrying pck) were introduced into the Δcra and parental strains. The coexpression of both Pck and Fdh1 led to an increase in succinate in both Δcra and wild-type strains, but the increase was more marked in the mutant strain, achieving a difference of almost 100% in succinate concentration compared to the parental strain in nonaerated M9 cultures after 24 h (2.90 ± 0.60 g liter−1 and 1.40 ± 0.05 g liter−1, respectively) (Fig. 5A). Induction of the enzymes did not cause significant changes in the metabolic profiles of the recombinants, apart from the increase in succinate synthesis (see Fig. S5 in the supplemental material).

FIG 5.

FIG 5

Production of succinate and 1,3-PDO in global regulator mutants. (A) E. coli BW25113 (wild type) and its Δcra derivative, both carrying plasmids pSBF2 (carrying fdh1 from C. boidinii) and pEcPck (carrying pck from E. coli), were grown in screw-cap tubes filled with M9 medium supplemented with glucose at 5 g liter−1 and yeast extract at 0.5 g liter−1 under nonaerated conditions for 24 h. The expression of fdh1 and pck from pSBF2 and pEcPck was induced by 0.5 mM IPTG added to the medium at the onset of the cultivation. CDW, cell dry weight (g liter−1). (B) E. coli BW25113 (wild type) and its Δcra and ΔarcA mutant derivatives, all harboring plasmids pBBR1MCS-2::dha (carrying the genes for 1,3-PDO synthesis from K. pneumoniae) and pPhaP328 (carrying phaP from Azotobacter sp. FA8), were grown in shaken flasks using LB or SDM supplemented with glycerol at 30 g liter−1 under fully aerated conditions for 24 h. LB expression of PhaP was induced by the addition of 0.5 mM m-toluic acid when cultures reached the early exponential phase (OD600 = 0.8). −PhaP, cultures grown without phaP induction (i.e., cultures grown in the absence of m-toluic acid); +PhaP, cultures grown in the presence of inducer. An asterisk (*) indicates significant differences when comparing mutant strains and the wild-type strain (t test, P < 0.05).

A recent study tested different variants of Cra in a Δpfl Δldh E. coli strain and resulted in a significant increase in succinate synthesis using a modified regulator that constitutively activates aceBAK (27). Although the modified Cra could affect metabolic fluxes differently from the absence of the regulator, the effect on succinate production of both kinds of manipulations supports the notion that cra is a key regulator that has an important effect on the synthesis of this added-value compound.

Enhancement of 1,3-PDO production in Δcra and ΔarcA mutants with PhaP.

The results described above indicated that the ΔarcA strain exhibited the best performance for 1,3-PDO synthesis when cultured in rich medium and fully aerated conditions (Fig. 3). This mutant strain displayed increased yield and glycerol consumption under these conditions (Table 5) and a higher tolerance to 1,3-PDO than any of the other strains (Table 2). On the other hand, Δcra mutants showed higher specific productivity of 1,3-PDO compared to the parental strain (Table 4). Since the Δcra strain has been shown to have a reduced ability to grow on gluconeogenic carbon sources such as glycerol in minimal medium (8), we hypothesized that this substrate could be funneled into 1,3-PDO rather than into biomass when grown on a rich medium. However, when LB cultures of this strain were conducted, only a slight increase in 1,3-PDO was detected (Fig. 3). Since Δcra derivatives exhibited an increased sensitivity to most of the stress agents tested, slight increases in 1,3-PDO could be due to an increased sensitivity to stressing culture conditions or fermentation inhibitors, which could prevent diol production.

Several different approaches have been used to overcome stress and tolerance problems, including evolution experiments in which resistant strains are selected by increasing amounts of the bioproduct (48), as well as other approaches. For example, the expression of chaperones has been used to enhance bacterial tolerance to diverse compounds, such as EtOH, in several strains (49). Previous studies in our laboratory have demonstrated the protective effect of PhaP, a PHB granule-associated protein from Azotobacter sp. FA8, against several types of stress (50). More recently, PhaP was shown to improve tolerance to biofuels and enhance EtOH and 1,3-PDO production in E. coli (51). In view of the results obtained in other E. coli strains, PhaP was overexpressed in the ΔarcA and Δcra mutants of the Keio collection to test its ability to enhance 1,3-PDO production.

Synthesis of 1,3-PDO was determined in fully aerated LB cultures of E. coli BW25113 and the ΔarcA and Δcra variants transformed with plasmid pPhaP328, harboring phaP under the control of the Pm promoter. Although overexpression of phaP caused a significant increase in diol production in the Δcra strain, this effect was unexpectedly less important than the effect observed in the wild-type background (Fig. 5B). This could indicate that, despite the increased sensitivity of the Δcra mutants to many stressors, the poor performance for 1,3-PDO synthesis could be related to other factors. These results suggest that this global regulator mutant would not be adequate for diol synthesis. In the case of the ΔarcA mutant, overexpression of PhaP resulted in a significant increase in 1,3-PDO production, both in comparison to the mutant strain without PhaP and also in comparison to the wild type with PhaP, resulting in a 2.3-fold increase. These data indicate that the beneficial effects of PhaP enhanced the metabolic effects of the ΔarcA deletion further, achieving an even higher increase in the production of the diol from glycerol. The final amount of 1,3-PDO produced by the ΔarcA strain in the presence of PhaP was 17 ± 1 g liter−1, with a yield of 0.73 ± 0.01 mol · mol−1 (Fig. 5B and Table 5).

Taking into account the promising results obtained with the ΔarcA mutant with PhaP, the behavior of this strain was analyzed under conditions more similar to those encountered in bioprocesses. Our first approach was to use a semidefined medium (SDM) more compatible with future applications. Shaken-flask cultures were grown in a modified M9 medium supplemented with 5 g liter−1 of yeast extract and 30 g liter−1 of glycerol. Only a slight reduction in diol titers was noticed for both strains expressing PhaP compared to LB cultures, and the ΔarcA strain again showed a remarkable increase in 1,3-PDO (1.84-fold) compared to the wild-type strain (Fig. 5B).

Lastly, repeated batch cultures of the wild-type and ΔarcA strains were grown in a bioreactor for 48 h in SDM. The glycerol concentration was restored to 30 g liter−1 when it reached levels lower than 5 g liter−1. The wild-type strain reached 11 g liter−1 of 1,3-PDO with a volumetric productivity of 0.24 ± 0.02 g liter−1 h−1, while the ΔarcA culture produced 73% more 1,3-PDO, achieving 19 g liter−1 and a productivity of 0.38 ± 0.01 g liter−1 h−1 (Fig. 6A and Table 6).

FIG 6.

FIG 6

Production of 1,3-PDO in ΔarcA mutants and effect of PhaP on diol synthesis. Cultures of E. coli BW25113, its ΔarcA derivative containing plasmid pBBR1MCS-2::dha (wild type and ΔarcA strains), and a ΔarcA mutant containing both plasmids pBBR1MCS-2::dha and pPhaP328 (ΔarcA+PhaP strain) were grown in SDM supplemented with glycerol at 30 g liter−1 in a bioreactor under fully aerated conditions for 48 h. The expression of phaP was induced by the addition of 0.5 mM m-toluic acid when cultures reached the early exponential phase (OD600 = 0.8). Representative data from two independent fermentations are presented. (A) 1,3-PDO production; (B) glycerol consumed; (C) growth. Plasmid pBBR1MCS-2::dha contains the dha operon from K. pneumoniae; plasmid pPhaP328 contains phaP from Azotobacter sp. FA8.

TABLE 6.

Production of 1,3-propanediol in repeated batch fermentationa

Strain μmaxb (h−1) Yield (mol 1,3-PDO · mol Gly−1) Volumetric productivity (g · liter−1 h−1) Specific productivity (g · liter−1 g CDW−1 h−1) Glycerol uptakec (g · liter−1 g CDW−1 h−1)
Wild type 0.39 ± 0.02 0.40 ± 0.06 0.24 ± 0.02 0.06 ± 0.01 0.18 ± 0.01
ΔarcA mutant 0.27 ± 0.02 0.41 ± 0.04 0.38 ± 0.01 0.08 ± 0.01 0.26 ± 0.03
ΔarcA+PhaP 0.34 ± 0.01 0.42 ± 0.01 0.53 ± 0.02 0.11 ± 0.01 0.31 ± 0.02
a

Cultures were grown in semidefined medium supplemented with glycerol at 30 g · liter−1 in a bioreactor under fully aerated conditions for 48 h. Results represent means ± the standard deviations of duplicate measurements from at least two independent cultures. The strains used were E. coli BW25113 as a control (wild type) and its ΔarcA derivative. All strains harbored plasmid pBBR1MCS-2::dha (carrying the genes for 1,3-PDO synthesis). Both ΔarcA strains carry, additionally, pPhaP328 (carrying phaP from Azotobacter sp. FA8). In the ΔarcA+PhaP strain, the expression of phaP was induced by the addition of 0.5 mM m-toluic acid when the cultures reached the early exponential phase (OD600 = 0.8). Gly, glycerol; CDW, cell dry weight.

b

Maximum specific growth rate.

c

Specific glycerol uptake rate.

Since arcA mutants are known to provide a reduced intracellular environment, some previous studies have suggested the potential use of these mutants for 1,3-PDO synthesis. However, deletion of this global regulator in Klebsiella pneumoniae (52) or in E. coli (53) led to only slight increases (between 6 and 16.7%) in the synthesis of 1,3-PDO, while in Citrobacter freundii the arcA deletion did not affect 1,3-PDO yield (54). In all these cases, additional mutations and genetic modifications were used during the development of overproducing strains, masking the effect of the arcA deletion. In contrast, a 73% increase in 1,3-PDO synthesis was obtained in the present work in a ΔarcA mutant containing no additional mutations. This highlights the importance of using a well-characterized E. coli strain in order to single out the particular effects of the global regulator manipulations.

When PhaP was expressed in the ΔarcA genetic background, the repeated batch cultures reached 24 g liter−1 of 1,3-PDO, which represents an increase of 2.2-fold compared to the wild type after 48 h (Fig. 6A). The final biomasses were similar for all strains, although the ΔarcA mutant showed a reduced growth rate compared to the wild-type strain (Fig. 6C) that was restored by the overexpression of phaP (Table 6). The wild-type strain ceased both 1,3-PDO synthesis and glycerol consumption after 24 h, while both ΔarcA mutants continued using glycerol to synthesize 1,3-PDO for more than 40 h. Cultures of the ΔarcA strain with PhaP consumed glycerol faster, which also increased the rate of 1,3-PDO synthesis, resulting in a higher productivity (0.53 ± 0.02 g liter−1 h−1) (Fig. 6B and Table 6). In view of these results, it can be hypothesized that the absence of ArcA caused the cells to continue using the substrate, since this was observed both with and without PhaP, while the presence of PhaP allowed the cells to grow faster and convert more glycerol into 1,3-PDO, an effect that was previously reported in other E. coli strains (50). The joint effects of these two manipulations allowed a very important increase in the production of 1,3-PDO, since the growth-enhancing effect of PhaP boosted the beneficial metabolic background generated by the arcA deletion even further.

Conclusion.

The combined analysis of multiple variables showed specific patterns for each global regulator mutation in E. coli BW25113 despite the extensive regulation exerted by the transcription factors and their coregulation of some gene targets (3, 44, 45). It is important to highlight that (i) the genome of this strain has been completely sequenced and does not contain additional mutations (55) that could mask or interfere with the effects of the regulators and that (ii) analyzing the different mutations in a uniform genetic background eliminates possible strain-dependent results. This approach enabled the characterization of the physiological consequences of altered carbon and redox fluxes driven by the global regulator deletions and singled out Cra and ArcA as the regulators with the most important effects on bacterial metabolism. Using the production of succinate and 1,3-PDO as a proof of concept, Δcra and ΔarcA mutants were subjected to further manipulations to obtain larger amounts of these compounds, demonstrating that the metabolic backgrounds of the mutants were suitable for the synthesis of bioproducts.

MATERIALS AND METHODS

Bacterial strains and plasmids.

E. coli BW25113 and its derivatives were obtained from Coli Genetic Stock Center (Yale University, New Haven, CT). Strains and plasmids are listed in Table 7. All mutant strains were transformed with plasmid pCP20 for kan cassette resistance removal (56), and the plasmid was eliminated by consecutive passages of bacteria in LB plates at 42°C. Excision of the kan cassette was confirmed by PCR.

TABLE 7.

Strains and plasmids

Strain, plasmid, or primer Relevant characteristics or sequence (5′-3′)a Source or referenceb
E. coli strains
    BW25113 F Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) λ rph-1 Δ(rhaD-rhaB)568 hsdR514 CGSC (31)
    Δrob mutant Same as BW25113, but Δrob-721::kan CGSC (31)
    Δcra mutant Same as BW25113, but ΔfruR786::kan CGSC (31)
    ΔarcA mutant Same as BW25113, but ΔarcA726::kan CGSC (31)
    ΔcreC mutant Same as BW25113, but ΔcreC724::kan CGSC (31)
Plasmids
    pCP20 Plasmid used for kan excision; Saccharomyces cerevisiae FLP λ cI857 λPR repA(Ts); Apr Cmr 20
    pSBF2 Plasmid pDHK30 carrying fdh from Candida boidinii under the control of the lac promoter; Kmr 64
    pEcPck Plasmid pTrc99A(1) carrying pck from E. coli under the control of the lac promoter; Apr 63
    pETLm Plasmid pBluescript II KS(−) carrying adhE from Leuconostoc mesenteroides; Apr 51
    pBBR1MCS-2::dha Plasmid pBBR1MCS-2 carrying dhaR, dhaG, dhaT, dhaB, dhaC, dhaE, and dhaF from Klebsiella pneumoniae GLC29; Kmr 41, 62
    pPHB-KF Plasmid pJP24 (58) carrying the phaCAB genes from Ralstonia eutropha (57) and kan-FRT gene from plasmid pKD4 (59); Apr Kmr This study
    pSEVA328 Broad-host-range vector; oriRK2, oriT; Cmr 61
    pPhaP328 Plasmid SEVA328 carrying the phaP gene from Azotobacter sp. strain FA8 under the control of the Pm promoter; Cmr This study
Primers
    PhaP-F ATT GGA TCC ACA CAG GAA ACA GCT ATG GCT TTT TTT GAT CTG This study
    PhaPLow TCG AAG CTT GCC GTC AGG CAG TCT T 60
a

Antibiotic resistance markers: Ap, ampicillin; Cm, chloramphenicol; Km, kanamycin.

b

CGSC, Coli Genetic Stock Center (Yale University, New Haven, CT).

Construction of pPHB-KF and pPhaP328.

An EcoRI-BamHI fragment from plasmid pTZ18U-PHB containing the phaCAB genes from Ralstonia eutropha (57) was ligated into plasmid pJP24 (58). A fragment containing the removable kan-FRT gene from plasmid pKD4 (59) was amplified by PCR and ligated into pJP24 as well. Plasmid pADP2 was used as the template for PCR amplification of a BamHI-HindIII fragment containing phaP from Azotobacter sp. FA8 (60). The PCR product was ligated to pSEVA328 (61) to obtain pPhaP328, which carries phaP under the control of the Pm promoter. Plasmid constructions were checked by PCR and agarose gel electrophoresis.

Growth media and culture conditions. (i) Metabolic profiles and tolerance assays.

M9 minimal medium (20) supplemented with glucose at 5 g liter−1 was used. The aeration conditions were established by a combination of agitation and the relationship between the volume of culture medium (Vm) and the volume of the flask (Vf) as follows: for full aeration, 200 rpm and Vm/Vf = 1/10; and for low aeration, 125 rpm and Vm/Vf = 1/2 (20). Penicillin bottles (50 ml) capped with cotton plugs and 10-ml glass vials covered with rubber caps were used for fully aerated and low-aeration conditions, respectively. For tolerance assays, concentrations of each compound (as indicated in Fig. 2 and the footnote for Table 2) were added to the medium before inoculation. In the case of volatile compounds (EtOH and ButOH), vials were capped with rubber plugs and aluminum seals. Nonaerated cultures were grown in 10-ml screw-cap tubes filled with medium agitated at 6 rpm to avoid cell sedimentation.

Redox stress tests were performed in M9 agar plates with the addition of toluidine blue at a 0.02% final concentration. Serial dilutions from overnight cultures were spotted over the plates to obtain isolated colonies, and colony diameters were determined after 24 h at 37°C.

All cultures were inoculated from overnight precultures grown under the same conditions as working cultures. Precultures were started from frozen glycerol stocks plated on LB agar medium, and two to three colonies were picked for each case.

(ii) Production of chemicals in recombinant strains.

For EtOH production, the low-aeration conditions described above were implemented for cultures grown in LB (containing 10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl per liter) supplemented with 10 g of glucose or 10 g of glycerol per liter incubated at 37°C for 24 h. All mutant and wild-type strains were transformed with plasmid pETLm (50). The expression of adhE was induced with 1 mM IPTG (isopropyl-β-d-thiogalactopyranoside) when an optical density at 600 nm (OD600) of 0.8 was reached.

In the case of 1,3-PDO, strains transformed with plasmid pBBR1MCS-2::dha (41, 62) were grown in M9 minimal medium or LB under full- and low-aeration conditions. In all cases, medium was supplemented with glycerol (10 g liter−1 and 30 g liter−1 were added for low and full aeration, respectively) and 1.5 μM vitamin B12. When pPhaP328 was used, phaP expression was induced with 0.5 mM m-toluic acid added at an OD600 of 0.8. PHB-producing strains transformed with the pPHB-KF plasmid were grown in LB medium with glucose 10 g liter−1 under low-aeration conditions in 100-ml cylinder flask bottles. Antibiotics (kanamycin, 50 μg ml−1; ampicillin, 100 μg ml−1; chloramphenicol, 20 μg ml−1) were added whenever needed.

(iii) Cultures of engineered Δcra mutant for enhanced succinic acid production.

Wild-type and Δcra strains, transformed with pEcpck (63) and pSBF2 (64), were grown under nonaerated conditions as described above for 24 h in M9 medium with the addition of 0.5 g liter−1 of yeast extract, 5 μg liter−1 of thiamine, and trace solution (containing [per liter] 2.78 mg of FeSO4·7H2O, 1.98 mg of MnCl2·4H2O, 2.81 mg of CoSO4·7H2O, 0.17 mg of CuCl2·2H2O, and 0.29 mg of ZnSO4·7H2O in 1 N HCl). In this case, a low-aeration preculture step was added before the nonaerated preculture to obtain larger amounts of biomass. Expression of fdh1 and pck was induced by the addition of 0.5 mM IPTG at an OD600 of 0.8. The culture medium also contained 100 mM NaHCO3 as a CO2 source.

(iv) 1,3-PDO fermentation conditions (repeated batch).

LB precultures grown in Erlenmeyer flasks containing 75 ml of medium under the fully aerated conditions defined above were used to inoculate a 3.7-liter bioengineering bioreactor filled with 1.5 liters of M9 medium containing (per liter) 6.0 g of Na2HPO4, 3.0 g of KH2PO4, 0.5 g of NaCl, 2.0 g of NH4Cl, 0.4 g of MgSO4, 0.01 g of CaCl2, and 0.06 g of ammonium iron(III) citrate. Next, 30 g liter−1 of glycerol, 5 g liter−1 of yeast extract, and 1.5 μM vitamin B12 and kanamycin were added. The pH was adjusted to 7 by the addition of 2 M NaOH and 1 M H2SO4. Dissolved oxygen was maintained at 20% during the whole cultivation by a cascade mode, and the air supply was set at between 0.5 and 1.5 liters min−1. The OD, biomass, and 1,3-PDO and glycerol titers were monitored during the 48-h fermentation. The glycerol concentration was restored to 30 g liter−1 when it reached levels below 5 g liter−1 in the culture supernatant.

Analytical determinations. (i) Organic acid determination.

Cultures were centrifuged at 5,000 rpm for 6 min, and supernatants were diluted 1:3 and 1:5 in water for the low-aeration and nonaerated conditions, respectively. The cell pellets obtained were dried at 65°C for 48 h for cell dry weight (CDW) measurements. Filtered (0.22-μm pore size) liquid samples were analyzed by high-pressure liquid chromatography (LC-20AT Prominence; Shimadzu Corp., Kyoto, Japan) equipped with a UV detector (SPD-20AV; Shimadzu Corp.) using an Aminex HTX-87H column (catalog no. 170 0140; Bio-Rad Laboratories, Inc., Hercules, CA). The mobile phase was 5 mM H2SO4 in water, and the flux rate was 0.6 ml min−1 at 50°C. Quantification was done at 215 nm, and analytical standards (Sigma-Aldrich Co., St. Louis, MO) were used.

(ii) EtOH, 1,3-PDO, and glycerol determinations.

Sample preparations and compound measurements were performed as previously indicated (50, 65). Briefly, samples were centrifuged and filtered as indicated for organic acids (see the previous paragraph), and 250 μl of each sample was diluted in 750 μl of EtOH or acetone for the 1,3-PDO or EtOH determination, respectively. Finally, the dilutions were vortexed for 1 min and centrifuged at 9,000 rpm and 3 min for salt precipitation. Gas chromatography (GC) was carried out using a 7820A chromatographic system equipped with a flame ionization detector (FID) and an automatic liquid sampler ALS 7693 (Agilent, Santa Clara, CA). HP-INNOWAX capillary column (30 m; 0.25-μm film thickness, and 0.25-mm internal diameter) was used with N2 as the carrier gas. Briefly, for glycol measurement, the GC oven was heated at 185°C for 3 min, then ramped up to 220°C at 40°C min−1, and held for 1 min. The injector and FID temperatures were set at 290 and 300°C, respectively, and the gas column flow was 2.5 ml min−1. For EtOH, the oven temperature was set at 35°C for 8 min. The injector and detector temperatures were 150 and 300°C, respectively. The nitrogen flow was 1 ml min−1. The split ratios were 30:1 and 90:1 for glycols and EtOH, respectively.

(iii) Glucose determination.

An enzymatic kit (Wiener Laboratorios SAIC, Rosario, Argentina) was utilized, and samples were previously centrifuged and diluted 1:5 in deionized water. The colorimetric reaction was measured with a UV-Vis spectrometer set at 505 nm.

(iv) PHB determination.

The cultures were centrifuged, and the supernatants were discarded. The amount of polymer was determined by GC as previously described (17). Pellets were lyophilized overnight, and 10-mg portions were placed in Teflon screw-cup vials. The pellets were heated at 100°C for 2 h with 2 ml of chloroform and 2 ml of 15% (vol/vol) sulfuric acid diluted in methanol. After cooling at room temperature, the aqueous phase was discarded, and the samples were washed twice with 2 ml of deionized water and dried over anhydrous Na2SO4. The resulting methyl esters of 3-hydroxybutyrate were quantified in the chromatographic system described above. An HP-5 nonpolar column was used (30 m; 0.25-μm film thickness, 0.32-mm internal diameter). The GC oven was initially heated at 60°C for 3 min and then to 110°C with a heat ramp of 45°C min−1 and finally held for 1.5 min. The injector and FID were set to 250 and 300°C, respectively. The split ratio was 45:1, and 1 μl was injected.

(v) Statistical analysis.

All of the experiments reported here were performed at least twice in a minimum of two independently grown cultures. The mean values of the corresponding parameter ± the standard deviations of triplicates for each assay are presented. The statistical significance of differences when comparing two strains was obtained using a two-tailed Student t test. Data were considered statistically significant when the P value was <0.05. In the case of bioreactor cultures, representative data from at least two independent cultures are shown.

Multivariate descriptive analysis was performed by unsupervised principal component analysis (PCA), discriminant analysis (DA), and hierarchical clustering analysis (HCA) using InfoStat Software. These tools were used to identify separation trends and to visualize the response of the working strains under the variety of conditions tested. A total of 21 variables were used in the statistical analysis, including tolerance assays, metabolic profiles, and the biomass yields of the strains in minimal medium. HCA was calculated using Euclidean distance approach, and the five groups were clustered using Ward's method.

Supplementary Material

Supplemental file 1
zam019188764s1.pdf (289.3KB, pdf)

ACKNOWLEDGMENTS

We are indebted to G. N. Bennett (Rice University, Houston, TX) and to P. Kim (Catholic University of Korea, Bucheon, Gyunggi, South Korea) for the kind gifts of plasmids pSBF2 and pEcPck, respectively. We are grateful to J. G. Cabrera Gomez and to A. Flora for providing plasmid pBBR1MCS-2::dha, to V. de Lorenzo for providing plasmid pSEVA328, and to P. I. Nikel for plasmid pETLm.

M.J.P. and M.P.M. are career investigators from Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, Argentina). D.E.E., R.D.P., and D.S.A. hold doctoral fellowships from CONICET.

We declare no conflict of interest.

Footnotes

Supplemental material for this article may be found at https://doi.org/10.1128/AEM.01337-18.

REFERENCES

  • 1.Bettenbrock K, Bai H, Ederer M, Green J, Hellingwerf KJ, Holcombe M, Kunz S, Rolfe MD, Sanguinetti G, Sawodny O, Sharma P, Steinsiek S, Poole RK. 2014. Towards a systems level understanding of the oxygen response of Escherichia coli. Adv Microb Physiol 64:65–114. doi: 10.1016/B978-0-12-800143-1.00002-6. [DOI] [PubMed] [Google Scholar]
  • 2.Shimizu K. 2013. Metabolic regulation of a bacterial cell system with emphasis on Escherichia coli metabolism. ISRN Biochem 2013:1–47. doi: 10.1155/2013/637897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kochanowski K, Gerosa L, Brunner SF, Christodoulou D, Nikolaev YV, Sauer U. 2017. Few regulatory metabolites coordinate expression of central metabolic genes in Escherichia coli. Mol Syst Biol 13:903. doi: 10.15252/msb.20167402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ruiz JA, de Almeida A, Godoy MS, Mezzina MP, Bidart GN, Méndez BS, Pettinari MJ, Nikel PI. 2012. Escherichia coli redox mutants as microbial cell factories for the synthesis of reduced biochemicals. Comput Struct Biotechnol J 3:e201210019. doi: 10.5936/csbj.201210019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nikel PI, Pettinari MJ, Galvagno MA, Méndez BS. 2008. Poly(3-hydroxybutyrate) synthesis from glycerol by a recombinant Escherichia coli arcA mutant in fed-batch microaerobic cultures. Appl Microbiol Biotechnol 77:1337–1343. doi: 10.1007/s00253-007-1255-7. [DOI] [PubMed] [Google Scholar]
  • 6.Botsford JL, Harman JG. 1992. Cyclic AMP in prokaryotes. Microbiol Rev 56:100–122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Saier MH, Ramseier TM. 1996. The catabolite repressor/activator (Cra) protein of enteric bacteria. Microbiology 178:3411–3417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chin AM, Feucht BU, Saier MH. 1987. Evidence for regulation of gluconeogenesis by the fructose phosphotransferase system in Salmonella typhimurium. J Bacteriol 169:897–899. doi: 10.1128/jb.169.2.897-899.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kotte O, Zaugg JB, Heinemann M. 2010. Bacterial adaptation through distributed sensing of metabolic fluxes. Mol Syst Biol 6:1–9. doi: 10.1038/msb.2010.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shimada T, Yamamoto K, Ishihama A. 2011. Novel members of the Cra regulon involved in carbon metabolism in Escherichia coli. J Bacteriol 193:649–659. doi: 10.1128/JB.01214-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zhang Z, Aboulwafa M, Saier MH. 2014. Regulation of crp gene expression by the catabolite repressor/activator, Cra, in Escherichia coli. J Mol Microbiol Biotechnol 24:135–141. doi: 10.1159/000362722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gunsalus RP. 2006. Control of electron flow in Escherichia coli: coordinated transcription of respiratory pathway genes. J Bacteriol 174:7069–7074. doi: 10.1128/jb.174.22.7069-7074.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Iuchi S, Lin EC. 1988. arcA (dye), a global regulatory gene in Escherichia coli mediating repression of enzymes in aerobic pathways. Proc Natl Acad Sci U S A 85:1888–1892. doi: 10.1073/pnas.85.6.1888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Shalel-Levanon S, San KY, Bennett GN. 2005. Effect of ArcA and FNR on the expression of genes related to the oxygen regulation and the glycolysis pathway in Escherichia coli under microaerobic growth conditions. Biotechnol Bioeng 92:147–159. doi: 10.1002/bit.20583. [DOI] [PubMed] [Google Scholar]
  • 15.Nizam SA, Zhu J, Ho PY, Shimizu K. 2009. Effects of arcA and arcB genes knockout on the metabolism in Escherichia coli under aerobic condition. Biochem Eng J 44:240–250. doi: 10.1016/j.bej.2008.12.017. [DOI] [Google Scholar]
  • 16.Lynch AS, Lin EC. 1996. Transcriptional control mediated by the ArcA two-component response regulator protein of Escherichia coli: characterization of DNA binding at target promoters. J Bacteriol 178:6238–6249. doi: 10.1128/jb.178.21.6238-6249.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nikel PI, Pettinari MJ, Galvagno MA, Méndez BS. 2006. Poly(3-hydroxybutyrate) synthesis by recombinant Escherichia coli arcA mutants in microaerobiosis. Appl Environ Microbiol 72:2614–2620. doi: 10.1128/AEM.72.4.2614-2620.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cariss SJL, Tayler AE, Avison MB. 2008. Defining the growth conditions and promoter-proximal DNA sequences required for activation of gene expression by CreBC in Escherichia coli. J Bacteriol 190:3930–3939. doi: 10.1128/JB.00108-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zhou L, Lei XH, Bochner BR, Wanner BL. 2003. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J Bacteriol 185:4956–4972. doi: 10.1128/JB.185.16.4956-4972.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Godoy MS, Nikel PI, Cabrera Gomez JG, Pettinari MJ. 2016. The CreC regulator of Escherichia coli, a new target for metabolic manipulations. Appl Environ Microbiol 82:244–254. doi: 10.1128/AEM.02984-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Nikel PI, Zhu J, San KY, Méndez BS, Bennett GN. 2009. Metabolic flux analysis of Escherichia coli creB and arcA mutants reveals shared control of carbon catabolism under microaerobic growth conditions. J Bacteriol 191:5538–5548. doi: 10.1128/JB.00174-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Martin RG, Rosner JL. 2002. Genomics of the marA/soxS/rob regulon of Escherichia coli: identification of directly activated promoters by application of molecular genetics and informatics to microarray data. Mol Microbiol 44:1611–1624. doi: 10.1046/j.1365-2958.2002.02985.x. [DOI] [PubMed] [Google Scholar]
  • 23.Bennik MHJ, Pomposiello PJ, Thorne DF, Demple B. 2000. Defining a rob regulon in Escherichia coli by using transposon mutagenesis. J Bacteriol 182:3794–3801. doi: 10.1128/JB.182.13.3794-3801.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Okochi M, Kurimoto M, Shimizu K, Honda H. 2008. Effect of global transcriptional regulators related to carbohydrate metabolism on organic solvent tolerance in Escherichia coli. J Biosci Bioeng 105:389–394. doi: 10.1263/jbb.105.389. [DOI] [PubMed] [Google Scholar]
  • 25.Deng Z, Shan Y, Pan Q, Gao X, Yan A. 2013. Anaerobic expression of the gadE-mdtEF multidrug efflux operon is primarily regulated by the two-component system ArcBA through antagonizing the H-NS mediated repression. Front Microbiol 4:194. doi: 10.3389/fmicb.2013.00194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lennen RM, Politz MG, Kruziki MA, Pfleger BF. 2013. Identification of transport proteins involved in free fatty acid efflux in Escherichia coli. J Bacteriol 195:135–144. doi: 10.1128/JB.01477-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhu LW, Xia ST, Wei LN, Li HM, Yuan ZP, Tang YJ. 2016. Enhancing succinic acid biosynthesis in Escherichia coli by engineering its global transcription factor, catabolite repressor/activator (Cra). Sci Rep 6:1–11. doi: 10.1038/s41598-016-0001-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Alexeeva S, Hellingwerf KJ, Teixeira de Mattos MJ. 2003. Requirement of ArcA for redox regulation in Escherichia coli under microaerobic but not anaerobic or aerobic conditions. J Bacteriol 185:204–209. doi: 10.1128/JB.185.1.204-209.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nizam SA, Shimizu K. 2008. Effects of arcA and arcB genes knockout on the metabolism in Escherichia coli under anaerobic and microaerobic conditions. Biochem Eng J 42:229–236. doi: 10.1016/j.bej.2008.06.021. [DOI] [Google Scholar]
  • 30.Son YJ, Phue JN, Trinh LB, Lee SJ, Shiloach J. 2011. The role of Cra in regulating acetate excretion and osmotic tolerance in Escherichia coli K-12 and E. coli B at high density growth. Microb Cell Fact 10:1–9. doi: 10.1186/1475-2859-10-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:1. doi: 10.1038/msb4100050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Grenier F, Matteau D, Baby V, Rodrigue S. 2014. Complete genome sequence of Escherichia coli BW25113. Genome Announc 2(5):e01038-14. doi: 10.1128/genomeA.01038-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Yao R, Kurata H, Shimizu K. 2013. Effect of cra gene mutation on the metabolism of Escherichia coli for a mixture of multiple carbon sources. Adv Biosci Biotechnol 4:477–486. doi: 10.4236/abb.2013.43A063. [DOI] [Google Scholar]
  • 34.Nikel PI, de Almeida A, Pettinari MJ, Méndez BS. 2008. The legacy of HfrH: mutations in the two-component system CreBC are responsible for the unusual phenotype of an Escherichia coli arcA mutant. J Bacteriol 190:3404–3407. doi: 10.1128/JB.00040-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Nikel PI, Pettinari MJ, Ramírez MC, Galvagno MA, Méndez BS. 2008. Escherichia coli arcA mutants: metabolic profile characterization of microaerobic cultures using glycerol as a carbon source. J Mol Microbiol Biotechnol 15:48–54. doi: 10.1159/000111992. [DOI] [PubMed] [Google Scholar]
  • 36.Goulas KA, Toste FD. 2016. Combining microbial production with chemical upgrading. Curr Opin Biotechnol 38:47–53. doi: 10.1016/j.copbio.2015.12.019. [DOI] [PubMed] [Google Scholar]
  • 37.Ruiz JA, Fernández RO, Nikel PI, Méndez BS, Pettinari MJ. 2006. dye (arc) mutants: insights into an unexplained phenotype and its suppression by the synthesis of poly (3-hydroxybutyrate) in Escherichia coli recombinants. FEMS Microbiol Lett 258:55–60. doi: 10.1111/j.1574-6968.2006.00196.x. [DOI] [PubMed] [Google Scholar]
  • 38.de Almeida A, Giordano AM, Nikel PI, Pettinari MJ. 2010. Effects of aeration on the synthesis of poly(3-hydroxybutyrate) from glycerol and glucose in recombinant Escherichia coli. Appl Environ Microbiol 76:2036–2040. doi: 10.1128/AEM.02706-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Yang M, Yun J, Zhang H, Magocha TA, Zabed H, Xue Y, Fokum E, Sun W, Qi X. 2018. Genetically engineered strains: application and advances for 1,3-propanediol production from glycerol. Food Technol Biotechnol 56:3–15. doi: 10.17113/ftb.56.01.18.5445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sun Y-Q, Shen J-T, Yan L, Zhou J-J, Jiang L-L, Chen Y, Yuan J-L, Feng E, Xiu Z-L. 2018. Advances in bioconversion of glycerol to 1,3-propanediol: prospects and challenges. Process Biochem 71:134–146. doi: 10.1016/j.procbio.2018.05.009. [DOI] [Google Scholar]
  • 41.Da Silva GP, De Lima CJB, Contiero J. 2015. Production and productivity of 1,3-propanediol from glycerol by Klebsiella pneumoniae GLC29. Catal Today 257:259–266. doi: 10.1016/j.cattod.2014.05.016. [DOI] [Google Scholar]
  • 42.Avison MB, Horton RE, Walsh TR, Bennett PM. 2001. Escherichia coli CreBC is a global regulator of gene expression that responds to growth in minimal media. J Biol Chem 276:26955–26961. doi: 10.1074/jbc.M011186200. [DOI] [PubMed] [Google Scholar]
  • 43.Pettinari MJ, Nikel PI, Ruiz JA, Méndez BS. 2008. ArcA redox mutants as a source of reduced bioproducts. J Mol Microbiol Biotechnol 15:41–47. doi: 10.1159/000111991. [DOI] [PubMed] [Google Scholar]
  • 44.Martínez-Antonio A, Collado-Vides J. 2003. Identifying global regulators in transcriptional regulatory networks in bacteria. Curr Opin Microbiol 6:482–489. doi: 10.1016/j.mib.2003.09.002. [DOI] [PubMed] [Google Scholar]
  • 45.Perrenoud A, Sauer U. 2005. Impact of global transcriptional regulation by ArcA, ArcB, Cra, Crp, Cya, Fnr, and Mlc on glucose catabolism in Escherichia coli. J Bacteriol 187:3171–3179. doi: 10.1128/JB.187.9.3171-3179.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kochanowski K, Volkmer B, Gerosa L, Haverkorn van Rijsewijk BR, Schmidt A, Heinemann M. 2013. Functioning of a metabolic flux sensor in Escherichia coli. Proc Natl Acad Sci U S A 110:1130–1135. doi: 10.1073/pnas.1202582110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Salmon KA, Hung S, Steffen NR, Krupp R, Baldi P, Hatfield GW, Gunsalus RP. 2005. Global gene expression profiling in Escherichia coli K12. J Biol Chem 280:15084–15096. doi: 10.1074/jbc.M414030200. [DOI] [PubMed] [Google Scholar]
  • 48.Nikel PI, Ramirez MC, Pettinari MJ, Méndez BS, Galvagno MA. 2010. Ethanol synthesis from glycerol by Escherichia coli redox mutants expressing adhE from Leuconostoc mesenteroides. J Appl Microbiol 109:492–504. doi: 10.1111/j.1365-2672.2010.04668.x. [DOI] [PubMed] [Google Scholar]
  • 49.Nicolaou SA, Gaida SM, Papoutsakis ET. 2010. A comparative view of metabolite and substrate stress and tolerance in microbial bioprocessing: from biofuels and chemicals, to biocatalysis and bioremediation. Metab Eng 12:307–331. doi: 10.1016/j.ymben.2010.03.004. [DOI] [PubMed] [Google Scholar]
  • 50.Mezzina MP, Wetzler DE, de Almeida A, Dinjaski N, Prieto MA, Pettinari MJ. 2015. A phasin with extra talents: a polyhydroxyalkanoate granule-associated protein has chaperone activity. Environ Microbiol 17:1765–1776. doi: 10.1111/1462-2920.12636. [DOI] [PubMed] [Google Scholar]
  • 51.Mezzina MP, Álvarez DS, Egoburo DE, Peña RD, Nikel PI, Pettinari MJ. 2017. A new player in the biorefineries field: phasin PhaP enhances tolerance to solvents and boosts ethanol and 1,3-propanediol synthesis in Escherichia coli. Appl Environ Microbiol 83:e00662-17. doi: 10.1128/AEM.00662-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Lu XY, Ren SL, Lu JZ, Zong H, Song J, Zhuge B. 2018. Enhanced 1,3-propanediol production in Klebsiella pneumoniae by a combined strategy of strengthening the TCA cycle and weakening the glucose effect. J Appl Microbiol 124:682–690. doi: 10.1111/jam.13685. [DOI] [PubMed] [Google Scholar]
  • 53.Cervin MA. May 2008. Process for the biological production of 1,3-propanediol with high yield. US patent 7,371,558 B2.
  • 54.Maervoet VET, De Maeseneire SL, Avci FG, Beauprez J, Soetaert WK, De Mey M. 2016. High yield 1,3-propanediol production by rational engineering of the 3-hydroxypropionaldehyde bottleneck in Citrobacter werkmanii. Microb Cell Fact 15:1–11. doi: 10.1186/s12934-015-0402-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Baba T, Huan HC, Datsenko K, Wanner BL, Mori H. 2008. The applications of systematic in-frame, single-gene knockout mutant collection of Escherichia coli K-12. Methods Mol Biol 416:183–194. doi: 10.1007/978-1-59745-321-9_12. [DOI] [PubMed] [Google Scholar]
  • 56.Cherepanov PP, Wackernagel W. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9–14. doi: 10.1016/0378-1119(95)00193-A. [DOI] [PubMed] [Google Scholar]
  • 57.Schroll G, Resch S, Gruber K, Wanner G, Lubitz W. 1998. Heterologous ΦX174 gene E-expression in Ralstonia eutropha: E-mediated lysis is not restricted to γ-subclass of proteobacteria. J Biotechnol 66:211–217. doi: 10.1016/S0168-1656(98)00128-X. [DOI] [PubMed] [Google Scholar]
  • 58.Nikel PI, Pettinari MJ, Méndez BS, Galvagno MA. 2005. Statistical optimization of a culture medium for biomass and poly(3-hydroxybutyrate) production by a recombinant Escherichia coli strain using agroindustrial byproducts. Int Microbiol 8:243–250. [PubMed] [Google Scholar]
  • 59.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.de Almeida A, Nikel PI, Giordano AM, Pettinari MJ. 2007. Effects of granule-associated protein PhaP on glycerol-dependent growth and polymer production in poly(3-hydroxybutyrate)-producing Escherichia coli. Appl Environ Microbiol 73:7912–7916. doi: 10.1128/AEM.01900-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Silva-Rocha R, Martínez-García E, Calles B, Chavarría M, Arce-Rodríguez A, De Las Heras A, Páez-Espino AD, Durante-Rodríguez G, Kim J, Nikel PI, Platero R, De Lorenzo V. 2013. The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res 41:666–675. doi: 10.1093/nar/gks1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Flora AB. 2015. Detecção e clonagem de genes de biossíntese de 1,3-propanodiol a partir de glicerol em Klebsiella pneumoniae GLC29. Programa de Pós-Graduação Interunidades em Biotecnologia USP-IPT-I, Istituto Butantan, Sao Paolo, Brazil. [Google Scholar]
  • 63.Wang W, Li Z, Xie J, Ye Q. 2009. Production of succinate by a pflB ldhA double mutant of Escherichia coli overexpressing malate dehydrogenase. Bioprocess Biosyst Eng 32:737–745. doi: 10.1007/s00449-009-0298-9. [DOI] [PubMed] [Google Scholar]
  • 64.Berríos-Rivera S. 2002. Metabolic engineering of Escherichia coli: increase of NADH availability by overexpressing an NAD+-dependent formate dehydrogenase. Metab Eng 4:217–229. doi: 10.1006/mben.2002.0227. [DOI] [PubMed] [Google Scholar]
  • 65.Egoburo DE, Diaz Peña R, Kolender A, Pettinari MJ. 2017. Optimization and validation of a GC-FID method for quantitative determination of 1,3-propanediol in bacterial culture aqueous supernatants containing glycerol. Chromatographia 80:1121–1127. doi: 10.1007/s10337-017-3310-6. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1
zam019188764s1.pdf (289.3KB, pdf)

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES